NIM
PFE icon

Nexus Investment Management’s Pfizer PFE Stock Holding History

Nexus Investment Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.7M Sell
1,023,770
-7,085
-0.7% -$185K 3.21% 15
2026
Q1 		$28.9M Buy
1,030,855
+39,630
+4% +$1.06M 4.05% 12
2025
Q4 		$24.7M Buy
991,225
+19,700
+2% +$497K 3.36% 13
2025
Q3 		$24.8M Buy
971,525
+96,478
+11% +$2.38M 3.51% 13
2025
Q2 		$21.2M Buy
875,047
+8,210
+0.9% +$191K 3.17% 17
2025
Q1 		$31.6M Buy
866,837
+48,550
+6% +$1.27M 3.58% 15
2024
Q4 		$21.7M Buy
818,287
+13,475
+2% +$366K 2.17% 24
2024
Q3 		$23.3M Buy
804,812
+4,555
+0.6% +$133K 2.28% 24
2024
Q2 		$22.4M Sell
800,257
-33,589
-4% -$925K 2.35% 23
2024
Q1 		$23.1M Buy
833,846
+90,470
+12% +$2.51M 2.23% 27
2023
Q4 		$21.4M Buy
743,376
+1,825
+0.2% +$55.2K 2.23% 29
2023
Q3 		$24.6M Buy
741,551
+5,820
+0.8% +$206K 2.78% 19
2023
Q2 		$27M Buy
735,731
+5,740
+0.8% +$223K 2.94% 17
2023
Q1 		$29.8M Buy
729,991
+18,250
+3% +$788K 3.29% 13
2022
Q4 		$36.5M Buy
711,741
+3,749
+0.5% +$180K 4.12% 5
2022
Q3 		$31M Buy
707,992
+5,925
+0.8% +$288K 3.86% 7
2022
Q2 		$36.8M Sell
702,067
-61,135
-8% -$3.12M 4.23% 5
2022
Q1 		$39.5M Sell
763,202
-10,370
-1% -$538K 4.15% 6
2021
Q4 		$45.7M Buy
773,572
+1,450
+0.2% +$71.8K 4.65% 3
2021
Q3 		$33.2M Sell
772,122
-6,678
-0.9% -$296K 3.59% 13
2021
Q2 		$30.5M Buy
778,800
+725
+0.1% +$28.2K 3.15% 16
2021
Q1 		$28.2M Buy
778,075
+36,250
+5% +$1.29M 3.21% 16
2020
Q4 		$27.6M Sell
741,825
-21,877
-3% -$802K 3.57% 15
2020
Q3 		$26.6M Buy
763,702
+2,898
+0.4% +$102K 4.03% 11
2020
Q2 		$23.6M Buy
760,804
+8,327
+1% +$283K 3.63% 10
2020
Q1 		$23.3M Buy
752,477
+39,135
+5% +$1.33M 4.11% 9
2019
Q4 		$26.5M Sell
713,342
-6,904
-1% -$246K 3.63% 12
2019
Q3 		$24.6M Buy
720,246
+475
+0.1% +$17.3K 3.49% 12
2019
Q2 		$29.6M Buy
719,771
+14,724
+2% +$585K 4.1% 7
2019
Q1 		$28.4M Sell
705,047
-8,590
-1% -$344K 4.2% 7
2018
Q4 		$29.6M Sell
713,637
-7,127
-1% -$296K 5.16% 4
2018
Q3 		$30.1M Sell
720,764
-8,941
-1% -$344K 4.31% 7
2018
Q2 		$25.1M Buy
729,705
+3,320
+0.5% +$113K 3.72% 9
2018
Q1 		$24.5M Buy
726,385
+42,845
+6% +$1.47M 3.76% 9
2017
Q4 		$23.5M Sell
683,540
-4,163
-0.6% -$142K 3.48% 9
2017
Q3 		$23.3M Buy
687,703
+2,993
+0.4% +$96.2K 3.64% 10
2017
Q2 		$21.8M Buy
684,710
+5,059
+0.7% +$160K 3.55% 10
2017
Q1 		$22.1M Buy
679,651
+10,951
+2% +$345K 3.76% 10
2016
Q4 		$20.6M Buy
668,700
+1,476
+0.2% +$45.1K 3.5% 12
2016
Q3 		$21.4M Buy
667,224
+6,977
+1% +$233K 3.91% 8
2016
Q2 		$22.1M Buy
660,247
+6,061
+0.9% +$193K 4.21% 5
2016
Q1 		$18.4M Sell
654,186
-2,424
-0.4% -$69.2K 3.47% 8
2015
Q4 		$20.1M Buy
656,610
+4,305
+0.7% +$135K 4.04% 6
2015
Q3 		$19.4M Buy
652,305
+3,689
+0.6% +$118K 4.07% 6
2015
Q2 		$20.6M Buy
648,616
+475
+0.1% +$15.5K 4.01% 7
2015
Q1 		$21.4M Buy
648,141
+9,854
+2% +$313K 4.21% 5
2014
Q4 		$18.9M Sell
638,287
-3,794
-0.6% -$109K 3.53% 9
2014
Q3 		$18M Buy
642,081
+19,763
+3% +$555K 3.4% 9
2014
Q2 		$17.5M Buy
622,318
+5,981
+1% +$170K 3.26% 9
2014
Q1 		$18.8M Buy
616,337
+9,749
+2% +$291K 3.67% 6
2013
Q4 		$17.6M Sell
606,588
-56,494
-9% -$1.64M 3.55% 5
2013
Q3 		$18.1M Sell
663,082
-5,997
-0.9% -$163K 3.85% 5
2013
Q2 		$18.6M Buy
+669,079
New +$18.5M 4.16% 5

Other funds holding PFE

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
SLAM
Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Nexus Investment Management's PFE Position: Q2 2026 in Review

Nexus Investment Management reduced its Pfizer (PFE) stake by 0.69% in Q2 2026, selling an estimated $185K and leaving 1,023,770 shares worth $24.7M. The position accounts for 3.21% of the portfolio, ranked #15.

Nexus Investment Management first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $45.7M in Q4 2021. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Nexus Investment Management held 1,023,770 shares of Pfizer worth $24.7M as of Q2 2026.
  • Nexus Investment Management sold 7,085 Pfizer shares in Q2 2026, an estimated $185K.
  • Pfizer made up 3.21% of Nexus Investment Management's portfolio in Q2 2026, its #15 holding.
  • Nexus Investment Management first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • Nexus Investment Management's Pfizer position peaked at $45.7M in Q4 2021.
  • 1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Nexus Investment Management's 13F filing for Q2 2026, filed 20 Jul 2026.